WHO ICTRP trial
Paracetamol versus ibuprofen in preterm infants with a hemodynamically…
EUCTR2015-003177-14-ES · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2015-003177-14-ES |
|---|---|
| Public title | Paracetamol versus ibuprofen in preterm infants with a hemodynamically significant patent ductus arteriosus: a randomized clinical trial. |
| Scientific title | Paracetamol versus ibuprofen in preterm infants with a hemodynamically significant patent ductus arteriosus: a randomized clinical trial. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Spain |
| Conditions | Persistent ductus arteriosus haemodynamically significant;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14] |
| Interventions | Product Name: Paracetamol Pharmaceutical Form: Solution for injection INN or Proposed INN: Paracetamol CAS Number: 103-90-2 Other descriptive name: PARACETAMOL Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal… |
| Registration date | Apr 20, 2016 |
| Secondary IDs | IBUPAR-Trial |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: